Critical Outcome Technologies Inc. (COTI) (TSX-V: COT) said it has been selected the International Trade Branch, Ontario Ministry of Economic Development & Trade to participate in a Trade Mission to BioPartnering North America in Vancouver, Canada taking place February 26-28, 2012.
BioPartnering North America is one of the premier annual international pharmaceutical partnering events. COTI will also be delivering a presentation at the conference highlighting the scientific merit and commercial potential of COTI-2.
Critical Outcome Technologies is one of 11 Ontario based human health bioscience organizations selected to participate in this Trade Mission.
